D Falls in FY 2000 Budget Proposal

President Bill Clinton's Office of Science and Technology Policy (OSTP) emphasized technology over science during the unveiling of the president's fiscal year (FY) 2000 budget request Feb. 1. The administration requested $78.42 billion for total civilian and military R&D--over $1 billion less than for FY1999. If Congress strictly adheres to that request next fall, most agencies that fund science would see their budgets at or below this year's level, after accounting for inflation. The two

Written byPaul Smaglik
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

President Bill Clinton's Office of Science and Technology Policy (OSTP) emphasized technology over science during the unveiling of the president's fiscal year (FY) 2000 budget request Feb. 1. The administration requested $78.42 billion for total civilian and military R&D--over $1 billion less than for FY1999. If Congress strictly adheres to that request next fall, most agencies that fund science would see their budgets at or below this year's level, after accounting for inflation. The two largest R&D fund providers--the National Institutes of Health (NIH) and the Department of Defense (DOD)--would get hit hardest in real-dollar terms.

Meanwhile, a heavily promoted administration initiative aims to take $366 million from six agencies and apply it toward developing faster computers, wireless networks, and new computer languages that would help scientists of all disciplines crunch data quicker, perhaps allowing for better modeling and simulation software. Vice President Al Gore first announced the program, named ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies